All articles

News

Single Use Support investing 20 Mio EUR in end-to-end solutions for cell & gene therapies

Single Use Support invests 20 Mio. EUR in development and research of Biopharma novel process solutions in cell & gene therapies. The Austrian company’s next upcoming innovation will be the launch of its own single-use bags.

micheal-eder

Michael Eder

November 17, 2021

End-to-end Solution

Enabling end-to-end process solutions for bottles

The Single Use Support end-to-end process for bottles can be applied independently from bottle manufacturer, it is modular and can be topped off with services such as qualifications, after-sales service and biopharma know-how.

Ramona Hintner

October 21, 2021

Single-use Technology

Stainless-Steel Container – universal tote for Biopharma

Biopharma totes are handy supporting devices to store and transport bulk drug substances Limited availabilities and increased lead times illustrate the everlasting high demand of Biopharma totes.

micheal-eder

Michael Eder

October 14, 2021

Cell & Gene Therapy

Single Use Support providing solutions for gene therapies

Biopharma solution provider Single Use Support announces an order from Genezen, a cell and gene therapy Contract Development and Manufacturing Organization (CDMO).

micheal-eder

Michael Eder

September 8, 2021

Single-use Consumables

Weak Point: Avoiding leakages of Single-Use Tubings in Biopharma

The quick and efficient aseptic transfer of highly valuable and at the same time extremely sensitive drug substances is a critical process step. Learn how to avoid leakages!

BRMO

Brian Moloney

September 1, 2021

End-to-end Solution

Does RoSS® resist vaporized hydrogen peroxide?

Infiltrating product solutions from life science companies or any other supplier into Biopharma environment is justifiably not so simple. RoSS has undergone tests to find out whether the treatment of H2O2 has any effect on the surface of all its components. 

elisabeth-haas-karagiannidis

Elisabeth Haas-Karagiannidis

August 30, 2021

Cell & Gene Therapy

Loss of drug substance - the challenges and chances of product loss

In recent years, if not decades, gene therapies have proven to be key drivers of growth in the pharmaceutical industry. Learn more how SUSupport takes on the chances in loss of drug substances.

Claus Exenberger - Single Use Support

Claus Exenberger

August 24, 2021

Cell & Gene Therapy

CAR NK therapy - natural killer cell therapy - what is that?

CAR-NK therapies are a new approach to combat cancer cells. 
This article sheds light on its advantages and logistical challenges  to avoid loss of these highly valuable drug substances and scalability.

micheal-eder

Michael Eder

August 19, 2021

Freeze & Thaw

How to achieve scalable freezing & thawing of biopharmaceuticals

What do you need for scalable freezing of biopharmaceuticals in single-use bags? 
Check out our Scalability Guide.

micheal-eder

Michael Eder

August 9, 2021

Freeze & Thaw

Fastest service to count on for all filling and freezing platforms

A fast and accessible after-sales service bring along numerous advantages for any manufacturer of biopharmaceuticals, be it CMOs, CDMOs or developing biotech companies. Here’s an overview of the most important aspects that cover a good after-sales support.

roland-jenewein

Roland Jenewein

August 3, 2021

Cell & Gene Therapy

Standardizing CAR-T therapy - Getting it scaled up!

The fields of gene and cellular therapy such as CAR-T and CGT therapy, are characterized by continuous development alongside rapid growth. Read everything about the scaling process of this industry!

micheal-eder

Michael Eder

July 29, 2021

Freeze & Thaw

Suppliers for freeze thaw platforms in biopharma – an overview

In order to preserve biopharmaceutical properties, bulk drug substances are commonly frozen before they are being stored or sent on their way around the globe. Read more about the players and their innovations!

micheal-eder

Michael Eder

June 29, 2021

Recommended Downloads

E-Book

eBook: Filling Gaps in Managing Large Volumes of Biologics

Aseptic aliquotation and cryopreservation of drug substances are crucial process steps in bioprocessing. Even though they’re not in the spotlight of biomanufacturing. In drug development and drug delivery, biologics must be transferred at numerous occasions. Along the journey of monoclonal antibodies, vaccines and more, the drug substance passes lots of process steps where liquid transfer is required. This is relevant for the transitions between upstream processing, downstream processing and fill & finish, but also within these manufacturing milestones. The market of fluid & cold chain management has great growth potential and is on its way to professionalization and industrialization. To meet the challenges of manufacturing drug substances, Single Use Support helps manufacturers and CDMOs to advance their fluid & cold chain management process to achieve a secure and efficient process for liquids on the basis of single-use bags.

E-Book

Whitepaper: How Controlled & Scalable Freezing Becomes Reality

Scalability around freezing means the ability to guarantee constant freezing kinetics on proteins (biopharmaceutical molecules) in all scales, filling volumes and loading scenarios. This guide covers how to achieve scalable freezing & thawing of biopharmaceuticals by showing What is scalability? Setup for controlled icefront growth speed Scalability results Outcomes

E-Book

Whitepaper: Automated Aseptic Filling

Automated Aseptic Filling Unprecedented flexibility to filling well